BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20095040)

  • 1. FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma.
    Kojima T; Shimazui T; Horie R; Hinotsu S; Oikawa T; Kawai K; Suzuki H; Meno K; Akaza H; Uchida K
    Genes Chromosomes Cancer; 2010 Apr; 49(4):379-89. PubMed ID: 20095040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism and function of decreased FOXO1 in renal cell carcinoma.
    Zhou L; Yin B; Liu Y; Hong Y; Zhang C; Fan J
    J Surg Oncol; 2012 Jun; 105(8):841-7. PubMed ID: 22213032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
    Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
    Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusterin plays an important role in clear renal cell cancer metastasis.
    Wang X; Luo L; Dong D; Yu Q; Zhao K
    Urol Int; 2014; 92(1):95-103. PubMed ID: 24008723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG is involved in the migration and invasion of clear cell renal cell carcinoma.
    Sheng Z; Liu Y; Qin C; Liu Z; Yuan Y; Hu F; Du Y; Yin H; Qiu X; Xu T
    J Clin Pathol; 2016 Jun; 69(6):497-504. PubMed ID: 26519488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.
    Deville JL; Bartoli C; Berenguer C; Fernandez-Sauze S; Kaafarani I; Delfino C; Fina F; Salas S; Muracciole X; Mancini J; Lechevallier E; Martin PM; Figarella-Branger D; Ouafik L; Daniel L
    Int J Cancer; 2009 Nov; 125(10):2307-15. PubMed ID: 19610056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
    Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
    Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
    Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis.
    Buchner A; Castro M; Hennig A; Popp T; Assmann G; Stief CG; Zimmermann W
    Urology; 2010 Aug; 76(2):507.e6-11. PubMed ID: 20538322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
    Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
    J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P; Ye L; Yang Y; Jiang WG
    Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
    Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
    Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling predicts survival in conventional renal cell carcinoma.
    Zhao H; Ljungberg B; Grankvist K; Rasmuson T; Tibshirani R; Brooks JD
    PLoS Med; 2006 Jan; 3(1):e13. PubMed ID: 16318415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma.
    Yao M; Huang Y; Shioi K; Hattori K; Murakami T; Sano F; Baba M; Kondo K; Nakaigawa N; Kishida T; Nagashima Y; Yamada-Okabe H; Kubota Y
    Int J Cancer; 2008 Sep; 123(5):1126-32. PubMed ID: 18546273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.